Publicacions en col·laboració amb investigadors/es de Karolinska University Hospital (11)

2024

  1. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522

    Annals of Oncology, Vol. 35, Núm. 5, pp. 429-436

2022

  1. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

    New England Journal of Medicine, Vol. 386, Núm. 6, pp. 556-567

2021

  1. A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

    Breast Cancer Research, Vol. 23, Núm. 1

2020

  1. Cranial ultrasound findings in preterm germinal matrix haemorrhage, sequelae and outcome

    Pediatric Research, Vol. 87, pp. 13-24

  2. Diagnostic and predictive value of Doppler ultrasound for evaluation of the brain circulation in preterm infants: a systematic review

    Pediatric Research, Vol. 87, pp. 50-58

  3. Pembrolizumab for early triple-negative breast cancer

    New England Journal of Medicine, Vol. 382, Núm. 9, pp. 810-821

  4. Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

    Annals of Oncology, Vol. 31, Núm. 5, pp. 569-581

  5. Preterm white matter injury: ultrasound diagnosis and classification

    Pediatric Research, Vol. 87, pp. 37-49

  6. State-of-the-art neonatal cerebral ultrasound: technique and reporting

    Pediatric Research, Vol. 87, pp. 3-12

  7. Ultrasound of acquired posterior fossa abnormalities in the newborn

    Pediatric Research, Vol. 87, pp. 25-36

2014

  1. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: The neuromodulation appropriateness consensus committee

    Neuromodulation, Vol. 17, Núm. 6, pp. 515-550